Pain in Inflammatory Joint Diseases (Nor-Pain)

Diakonhjemmet Hospital

Status: Not yet enrolling

Conditions: Arthritis, Juvenile Idiopathic; Arthritis; Arthritis, Reactive; Arthritis, Psoriatic; Spondyloarthritis (SpA); Arthritis,Rheumatoid

Treatments: Drug: Biological or targeted synthetic DMARD

Study type: Observational

Funder types: Other

Identifiers

NCT06718569

DS-00850

708967 (Other Identifier)

Details and patient eligibility

About

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory arthritis, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Enrollment: 350 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who initiate or switch biological or targeted synthetic DMARDs

Exclusion criteria

• None

Trial design

350 participants in 1 patient group

Patients who initiate or switch biological or targeted synthetic DMARD

Description:

All patients initiate or switch biological or targeted synthetic DMARD

Treatment:

Drug: Biological or targeted synthetic DMARD